Literature DB >> 17403880

Differential innate immune cell activation and proinflammatory response in Anaplasma phagocytophilum infection.

Kyoung-Seong Choi1, Tonya Webb, Mathias Oelke, Diana G Scorpio, J Stephen Dumler.   

Abstract

Human granulocytic anaplasmosis (HGA) is caused by the obligate intracellular bacterium Anaplasma phagocytophilum. The critical role of gamma interferon (IFN-gamma) for induction of severe inflammatory histopathology, even in the absence of a significant bacterial load, was previously demonstrated in a murine model of HGA. We hypothesized that NK, NKT, and possibly CD8(+) cytotoxic T cells participate in the development of histopathologic lesions with A. phagocytophilum infection. Mice were mock infected or infected with low- or high-passage A. phagocytophilum and assayed for hepatic histopathology and splenocyte immunophenotype during the first 21 days after infection. Compared to high-passage A. phagocytophilum-infected mice, low-passage A. phagocytophilum-infected mice had more severe hepatic lesions and increased apoptosis. The hepatic histopathology severity in low-passage A. phagocytophilum-infected mice peaked on day 2 at the time of peak plasma IFN-gamma levels and gradually decreased through day 21. Low-passage A. phagocytophilum-infected mice also showed significantly increased levels of lymphocyte NK1.1/FasL expression on days 4 to 7 corresponding to early, severe hepatic inflammation, whereas the levels of NKT cells were substantially lower on day 4, suggesting that there was NKT cell involvement. This result supports the concept that NK1.1(+) cells, including NK and NKT cells, are major components in the early pathogenesis of A. phagocytophilum infection.

Entities:  

Mesh:

Year:  2007        PMID: 17403880      PMCID: PMC1932852          DOI: 10.1128/IAI.00098-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo.

Authors:  E Assarsson; T Kambayashi; J K Sandberg; S Hong; M Taniguchi; L Van Kaer; H G Ljunggren; B J Chambers
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

Review 2.  Liver NKT cells: an account of heterogeneity.

Authors:  Masashi Emoto; Stefan H E Kaufmann
Journal:  Trends Immunol       Date:  2003-07       Impact factor: 16.687

3.  The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion.

Authors:  Michael T Wilson; Cecilia Johansson; Danyvid Olivares-Villagómez; Avneesh K Singh; Aleksandar K Stanic; Chyung-Ru Wang; Sebastian Joyce; Mary Jo Wick; Luc Van Kaer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

4.  Serum cytokine responses during acute human granulocytic ehrlichiosis.

Authors:  J S Dumler; E R Trigiani; J S Bakken; M E Aguero-Rosenfeld; G P Wormser
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

5.  Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia.

Authors:  M Akkoyunlu; E Fikrig
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

6.  Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis.

Authors:  M E Martin; K Caspersen; J S Dumler
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

7.  Experimental inoculation with human granulocytic Ehrlichia agent derived from high- and low-passage cell culture in horses.

Authors:  N Pusterla; J E Madigan; K M Asanovich; J S Chae; E Derock; C M Leutenegger; J B Pusterla; H Lutz; J S Dumler
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

8.  Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model.

Authors:  M E Martin; J E Bunnell; J S Dumler
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

9.  Cutting edge: protective cell-mediated immunity to Listeria monocytogenes in the absence of myeloid differentiation factor 88.

Authors:  Sing Sing Way; Tobias R Kollmann; Adeline M Hajjar; Christopher B Wilson
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

10.  Toll-like receptor 2 contributes to liver injury by Salmonella infection through Fas ligand expression on NKT cells in mice.

Authors:  Hideyuki Shimizu; Tetsuya Matsuguchi; Yoshihide Fukuda; Isao Nakano; Tetsuo Hayakawa; Osamu Takeuchi; Shizuo Akira; Masayuki Umemura; Takashi Suda; Yasunobu Yoshikai
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

View more
  14 in total

Review 1.  The role of CD8 T lymphocytes in rickettsial infections.

Authors:  David H Walker; J Stephen Dumler
Journal:  Semin Immunopathol       Date:  2015-04-01       Impact factor: 9.623

2.  Receptor interacting protein-2 contributes to host defense against Anaplasma phagocytophilum infection.

Authors:  Bindu Sukumaran; Yasunori Ogura; Joao H F Pedra; Koichi S Kobayashi; Richard A Flavell; Erol Fikrig
Journal:  FEMS Immunol Med Microbiol       Date:  2012-07-23

Review 3.  Anaplasma phagocytophilum: deceptively simple or simply deceptive?

Authors:  Maiara S Severo; Kimberly D Stephens; Michail Kotsyfakis; Joao Hf Pedra
Journal:  Future Microbiol       Date:  2012-06       Impact factor: 3.165

Review 4.  Adaptive immunity to Anaplasma pathogens and immune dysregulation: implications for bacterial persistence.

Authors:  Wendy C Brown
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2012-01-04       Impact factor: 2.268

Review 5.  Human ehrlichiosis and anaplasmosis.

Authors:  Nahed Ismail; Karen C Bloch; Jere W McBride
Journal:  Clin Lab Med       Date:  2010-03       Impact factor: 1.935

Review 6.  The biological basis of severe outcomes in Anaplasma phagocytophilum infection.

Authors:  J Stephen Dumler
Journal:  FEMS Immunol Med Microbiol       Date:  2011-12-19

7.  c-Jun NH2-terminal kinase 2 inhibits gamma interferon production during Anaplasma phagocytophilum infection.

Authors:  Joao H F Pedra; Jochen Mattner; Jian Tao; Steven M Kerfoot; Roger J Davis; Richard A Flavell; Philip W Askenase; Zhinan Yin; Erol Fikrig
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

8.  Impairment of gamma interferon signaling in human neutrophils infected with Anaplasma phagocytophilum.

Authors:  Uta Bussmeyer; Arup Sarkar; Kirsten Broszat; Tanja Lüdemann; Sonja Möller; Ger van Zandbergen; Christian Bogdan; Martina Behnen; J Stephen Dumler; Friederike D von Loewenich; Werner Solbach; Tamás Laskay
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

9.  Mitogenic component in polar lipid-enriched Anaplasma phagocytophilum membranes.

Authors:  Kyoung-Seong Choi; J Stephen Dumler
Journal:  Clin Vaccine Immunol       Date:  2007-08-08

10.  Comparison and characterization of granulocyte cell models for Anaplasma phagocytophilum infection.

Authors:  Kristen E Rennoll-Bankert; Sara H Sinclair; Marguerite A Lichay; J Stephen Dumler
Journal:  Pathog Dis       Date:  2013-12-20       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.